Skip to content
Rivet Health Law, PLC

Insights

LCDs for Certain Skin Substitutes Withdrawn

Published January 21, 2026 · Updated January 22, 2026

In briefEffective immediately, CMS’ A/B Medicare Administrative Contractors (MACs) are withdrawing the Local Coverage Determinations (LCDs) for Skin Substitute Grafts/Cellular and Tissue-Based Products…

Sterile wound-care supplies on a clinical tray

Effective immediately, CMS’ A/B Medicare Administrative Contractors (MACs) are withdrawing the Local Coverage Determinations (LCDs) for Skin Substitute Grafts/Cellular and Tissue-Based Products for the Treatment of Diabetic Foot Ulcers and Venous Leg Ulcers that were scheduled to become effective on January 1, 2026. 

Newsletter

Insights in your inbox

New articles on healthcare law and revenue cycle, sent through the firm newsletter.

Do not include protected health information, medical records, or other confidential patient information.

This article is educational. It is not legal advice and does not create an attorney-client relationship. Facts, contracts, and appeal windows control the next step.

When the file is in front of you

Bring the letter, the remittance, or the agreement.

If this Insight raised a question about a claim, audit, or policy, the first conversation is about the facts.

Contact Us